Ji Li

Ji Li is an experienced professional in the biotechnology and pharmaceutical sectors, currently serving as the Head of Business Development, Finance & Operations at Immune-Onc Therapeutics. In this role, which he held from January 2019 to February 2021, he was responsible for overseeing strategic partnerships and financial operations within the company. Prior to this position, he also served as the Director of Alliance Management & Business Operations at Immune-Onc from January 2018 to December 2018, and as Chief of Staff from August 2018 to January 2022.2

Ji Li's educational background includes a Ph.D. from Columbia University, where he studied from 2004 to 2010, and a Bachelor of Science from Peking University (2000-2004).2 His extensive career includes roles at various organizations, such as Natera and Navigant, where he focused on marketing strategy and consulting, respectively.2 Additionally, he has experience as a co-founder of AKI Therapeutics and has held positions in venture capital with Lilly Asia Ventures.12

His professional journey reflects a strong focus on business development and operational leadership within the life sciences industry.